If COVID-19 Is a Respiratory Disease, Why Are We Not Addressing It In The Nose?
A Pathophysiological Perspective on COVID-19’s Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.
Infection Chemotherapy. Sep 2020. doi: 10.3947/ic.2020.52.3.335. Epub 2020 Jul 15. – Marcos A Sanchez-Gonzalez, Dave Moskowitz, Priya D Issuree, George Yatzkan, Syed A A Rizvi, Kenneth Day
Intranasal Antiviral Drug Delivery and Coronavirus Disease (COVID-19):
A State-of-the-Art Review.
Otolaryngol - Head and Neck Surgery. July 14, 2020. doi: 10.1177/0194599820933170. Online ahead of print. – Thomas S. Higgins, MD, MSPH, Arthur W. Wu, MD, Elisa A Illing, et. al.
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.
New England Journal of Medicine. Mar 19, 2020. – Lirong Zou, M.Sc., Feng Ruan, M.Med., Mingxing Huang, Ph.D., et. al.